Clinical Trials
30 trialsPALG-AML1/2016
Polish Adult Leukemia Group
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
ALL-MB 2008
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
ALL-MB 2015
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Interfant06
Dutch Childhood Oncology Group
LAM99P
Gruppo Italiano Malattie EMatologiche dell'Adulto
Modified MRCUKALLâ…«/ECOGE2993 Regimen for ALL
Sun Yat-sen University
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
The First Hospital of Jilin University
Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years
ChineseAMS
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
National University Hospital, Singapore
Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
National Cancer Institute (NCI)
PALG-AML2012
Polish Adult Leukemia Group
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
Centre Henri Becquerel
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
University Hospital Muenster
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
Technische Universität Dresden
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
Antisoma Research
AIvsAD
Cooperative Study Group A for Hematology
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)
Japan Adult Leukemia Study Group